M&A Deal Summary

Revvity Acquires Shanghai Spectrum Instruments Co.

On May 23, 2018, Revvity acquired technology hardware company Shanghai Spectrum Instruments Co.

Acquisition Highlights
  • This is Revvity’s 1st transaction in the Technology Hardware sector.
  • This is Revvity’s 3rd transaction in China.

M&A Deal Summary

Date 2018-05-23
Target Shanghai Spectrum Instruments Co.
Sector Technology Hardware
Buyer(s) Revvity
Deal Type Add-on Acquisition

Target

Shanghai Spectrum Instruments Co.

Shanghai, China
Shanghai Spectrum Instruments Co., Ltd. is a provider of an analytical solutions and services to a wide range of research, academic, government, pharmaceutical, industrial, life sciences and chemical analysis laboratories. Its portfolio includes photoelectric colorimeters, UV-Vis spectrophotometers, atomic absorption spectrophotometers and accessories.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Revvity

Waltham, Massachusetts, United States

Category Company
Founded 1937
Sector Medical Products
Employees11,000
Revenue 2.8B USD (2024)
DESCRIPTION

Revvity provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. Revvity is revolutionizing what’s possible in healthcare, with specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Revvity was formed in 1937 and is based in Waltham, Massachusetts.


DEAL STATS #
Overall 29 of 37
Sector: Technology Hardware M&A 1 of 1
Type: Add-on Acquisition M&A Deals 27 of 35
Country: China M&A 3 of 3
Year: 2018 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-19 EUROIMMUN

Luebeck, Germany

EUROIMMUN is a producer of test systems and automation solutions for medical laboratory diagnostics. EUROIMMUN was founded in 1987 and is based in Luebeck, Germany.

Buy $1.3B
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-10-31 PerkinElmer - Quantitative Pathology Solutions

Waltham, Massachusetts, United States

PerkinElmer's Quantitative Pathology Solutions provides High-parameter analysis of biological tissue samples provides critical spatial context in studies of autoimmune disease, immune-oncology and many other research areas.

Sell -